reStructuring America Pharma 4.0 Asset Management

The pharmaceutical industry was required to incorporate planned improvements sooner than anticipated. Successes
that can be replicated and issues to avoid can be transferred among industries.
Bob Smith, CAI Principal Consultant, Asset Management and Reliability and ALN Senior Fellow; Mark Giuliani, ALN Senior
Fellow, President, Giuliani Digital; Nick Kissel, Director, CMMS Data Group
Special thanks to the International Pharmaceutical Engineers Association